Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

Non-alcoholic fatty liver disease (NAFLD) is an important common comorbidity in individuals with type 2 diabetes (T2DM). Although some glucagon-like peptide-1 receptor agonists (GLP-1RAs) have beneficial effects on NAFLD, the efficacy of once-weekly semaglutide has not been established. This was a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomoto, Hiroshi, Takahashi, Yuka, Takano, Yoshinari, Yokoyama, Hiroki, Tsuchida, Kazuhisa, Nagai, So, Miya, Aika, Kameda, Hiraku, Cho, Kyu Yong, Nakamura, Akinobu, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459529/
https://www.ncbi.nlm.nih.gov/pubmed/37631377
http://dx.doi.org/10.3390/pharmaceutics15082163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459529/
https://www.ncbi.nlm.nih.gov/pubmed/37631377
http://dx.doi.org/10.3390/pharmaceutics15082163

Ejemplares similares